Skip to content
★ Sign in to follow
AB
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (11 ops.)
€2.2M

Latest filing published 30 May 2007 for BIOGEN INC..

Insider track record

Disclosed buys
0
Disclosed sells
11
Signal history

No signal scores available.

Alan Belzer: trading record in brief

Alan Belzer is a declared insider of Biogen Inc., with filings sourced from SEC (Form 4). The record holds 15 filings, for trades running from 24 July 2006 to 25 May 2007.

The open-market record consists of 11 sales worth €2.2M, with no purchase. Outside the open market, there are 4 option exercises.

The latest filing, published on 30 May 2007, reports an option exercise in Biogen Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Alan Belzer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ◇
    DirectorExecutivesBiogen Inc.
    0SEC
    1,250 sharesCommon StockSEC:0001209191-07-033776:0
  • ◇
    DirectorExecutivesBiogen Inc.
    439,640 USD0SEC
    29,000 shares@ US$15.16Common StockSEC:0001209191-06-042639:0
  • ▼
    DirectorExecutivesBiogen Inc.
    100,750 USD0SEC
    2,500 shares@ US$40.30Common StockSEC:0001209191-06-042639:1
  • ▼
    DirectorExecutivesBiogen Inc.
    304,575 USD0SEC
    7,500 shares@ US$40.61Common StockSEC:0001209191-06-042639:2
  • ▼
    DirectorExecutivesBiogen Inc.
    205,650 USD0SEC
    5,000 shares@ US$41.13Common StockSEC:0001209191-06-042639:3
  • ▼
    DirectorExecutivesBiogen Inc.
    205,900 USD0SEC
    5,000 shares@ US$41.18Common StockSEC:0001209191-06-042639:4
  • ▼
    DirectorExecutivesBiogen Inc.
    206,600 USD0SEC
    5,000 shares@ US$41.32Common StockSEC:0001209191-06-042639:5
  • ▼
    DirectorExecutivesBiogen Inc.
    165,800 USD0SEC
    4,000 shares@ US$41.45Common StockSEC:0001209191-06-042639:6
  • ◇
    DirectorExecutivesBiogen Inc.
    303,200 USD0SEC
    20,000 shares@ US$15.16Common StockSEC:0001209191-06-042414:0
  • ▼
    DirectorExecutivesBiogen Inc.
    101,450 USD0SEC
    2,500 shares@ US$40.58Common StockSEC:0001209191-06-042414:1
  • ▼
    DirectorExecutivesBiogen Inc.
    306,450 USD0SEC
    7,500 shares@ US$40.86Common StockSEC:0001209191-06-042414:2
  • ▼
    DirectorExecutivesBiogen Inc.
    204,500 USD0SEC
    5,000 shares@ US$40.90Common StockSEC:0001209191-06-042414:3
  • ▼
    DirectorExecutivesBiogen Inc.
    204,550 USD0SEC
    5,000 shares@ US$40.91Common StockSEC:0001209191-06-042414:4
  • ◇
    DirectorExecutivesBiogen Inc.
    303,200 USD0SEC
    20,000 shares@ US$15.16Common StockSEC:0001209191-06-042414:5
  • ▼
    DirectorExecutivesBiogen Inc.
    831,000 USD0SEC
    20,000 shares@ US$41.55Common StockSEC:0001209191-06-042414:6

15 of 15 declarations